Knockdown of glycogen branching enzyme (GBE1) downstream of HIF1 in lung adenocarcinoma led to an increase in CCL5 expression and recruited more cytotoxic CD8+ T lymphocytes to contribute to tumor regression (32). This evidence concerns the gene CCL5 and lung adenocarcinoma.